Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 34, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 February 2025 - 8:51

Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 34, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/jakavi

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters